Nucleai and Propath UK announce partnership for end-to-end AI-powered spatial analysis of a 30-plex immunofluorescence immuno-oncology panel

Combining the power of spatial biology and AI, Propath and Nucleai push the boundaries of pathology tissue analytics to develop a novel, high multiplexed immunofluorescence (IF) panel and associated

Related Keywords

Dave Swatman ,Nanostring Geomx ,Kostenloser Wertpapierhandel ,Krish Soni ,Avi Viedman ,Akoya Phenocycler , ,United Kingdom ,Propath United Kingdom ,Teal Foxp ,Business Wire ,Chief Executive ,Propath United ,Nucleai ,Ropath ,Nnounce ,Partnership ,Owered ,1spatial ,Analysis ,Flex ,Immunofluorescence ,Immuno ,Ncology ,Panel ,